AstraZeneca completes equity investment agreement with Cellectis
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
The company plans to add 1700 beds by FY27 through the organic route
New leadership team announced at NATHEALTH Annual General Meeting 2024
Hepatitis B infects over 40 million people in India
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
ANVISA issues CGMP to Concord Biotech’s Unit I
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Subscribe To Our Newsletter & Stay Updated